Rank 81 • AI & Clinical Intelligence
Synapse Medicine
Provides clinical medication intelligence software to prevent adverse drug events and manage complex pharmaceutical therapies.
Visit website- Signal Score
- 84.5
- Total raised
- $35M
- Stage
- Series B
- Founded
- 2017
- Headquarters
- Bordeaux, France
- Region
- Europe
Their signal
Utilizes advanced NLP to safeguard medication prescribing pathways across hospitals and telemedicine startups, establishing an essential clinical safety layer.
Signal Score 84.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.